Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5).
Journal Article (Editorial)
Full Text
Duke Authors
Cited Authors
- Ohman, EM; Roe, MT
Published Date
- May 2011
Published In
- Thromb Haemost
Volume / Issue
- 105 / 5
Start / End Page
- 763 - 765
PubMed ID
- 21394382
Electronic International Standard Serial Number (EISSN)
- 2567-689X
Digital Object Identifier (DOI)
- 10.1160/TH11-03-0159
Language
- eng
Conference Location
- Germany